Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
49.82
-0.48 (-0.95%)
Dec 3, 2024, 1:49 PM EST - Market open

Twist Bioscience Revenue

In the fiscal year ending September 30, 2024, Twist Bioscience had annual revenue of $312.97M with 27.69% growth. Twist Bioscience had revenue of $84.71M in the quarter ending September 30, 2024, with 26.53% growth.

Revenue (ttm)
$312.97M
Revenue Growth
+27.69%
P/S Ratio
9.32
Revenue / Employee
$340,559
Employees
919
Market Cap
2.96B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024312.97M67.87M27.69%
Sep 30, 2023245.11M41.54M20.41%
Sep 30, 2022203.57M71.23M53.83%
Sep 30, 2021132.33M42.23M46.87%
Sep 30, 202090.10M35.72M65.67%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 9.47B
Amedisys 2.32B
LifeStance Health Group 1.21B
HUTCHMED (China) 610.81M
Inari Medical 574.50M
Amicus Therapeutics 493.67M
TransMedics Group 401.09M
Zai Lab 355.75M
Revenue Rankings